C07D 211/06
Having no double bonds between ring members or between ring members and
Official title: having no double bonds between ring members or between ring members and non-ring members
C07D211/06 (Having no double bonds between ring members or between ring members and) appears on 7,284 US grants and 6,497 published applications in this corpus.
Search patents in C07D- Granted patents
- 7,284
- Published applications
- 6,497
- Assignees
- 2,372
- Inventors
- 17,703
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 87 | 0 |
| 1977 | 118 | 0 |
| 1978 | 137 | 0 |
| 1979 | 96 | 0 |
| 1980 | 106 | 0 |
| 1981 | 95 | 0 |
| 1982 | 92 | 0 |
| 1983 | 79 | 0 |
| 1984 | 66 | 0 |
| 1985 | 93 | 0 |
| 1986 | 69 | 0 |
| 1987 | 61 | 0 |
| 1988 | 68 | 0 |
| 1989 | 89 | 0 |
| 1990 | 84 | 0 |
| 1991 | 99 | 0 |
| 1992 | 106 | 0 |
| 1993 | 122 | 0 |
| 1994 | 108 | 0 |
| 1995 | 95 | 0 |
| 1996 | 117 | 0 |
| 1997 | 198 | 0 |
| 1998 | 158 | 0 |
| 1999 | 156 | 0 |
| 2000 | 154 | 0 |
| 2001 | 170 | 52 |
| 2002 | 224 | 241 |
| 2003 | 203 | 311 |
| 2004 | 181 | 388 |
| 2005 | 166 | 336 |
| 2006 | 179 | 347 |
| 2007 | 156 | 290 |
| 2008 | 151 | 248 |
| 2009 | 215 | 306 |
| 2010 | 204 | 334 |
| 2011 | 161 | 275 |
| 2012 | 211 | 217 |
| 2013 | 216 | 207 |
| 2014 | 200 | 248 |
| 2015 | 220 | 278 |
| 2016 | 201 | 276 |
| 2017 | 244 | 253 |
| 2018 | 191 | 260 |
| 2019 | 217 | 220 |
| 2020 | 179 | 238 |
| 2021 | 174 | 199 |
| 2022 | 127 | 210 |
| 2023 | 131 | 236 |
| 2024 | 105 | 192 |
| 2025 | 124 | 209 |
| 2026 | 81 | 126 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- P38alpha mitogen-activated protein kinase inhibitors6 Oct 2026US 12,753,184 B2Gen1E Lifesciences Inc.
- Cationic lipid having disulfide bond, lipid membrane structure including same, nucleic acid introduction agent and pharmaceutical composition containing any one of same, method for introducing nucleic acid into cell or target cell, and method for producing cellular pharmaceutical29 Sep 2026US 12,746,202 B2National University Corporation Chiba University
- Capsaicin analogs and uses thereof29 Sep 2026US 12,747,200 B2Young BioPharma, LLC
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Substituted diaryl compound as well as preparation method and application thereof29 Sep 2026US 12,747,209 B2Shandong First Medical. Univ & Shandong Academy of Medical Sciences
- Cobalt-catalyzed carbonylative alkene hydrofunctionalizations promoted by visible light8 Oct 2026US 2026/0308103 A1
- Probenecid compounds for the treatment of inflammasome-mediated lung disease8 Oct 2026US 2026/0308131 A1Bacainn Biotherapeutics, Ltd.
- Novel compound or salt thereof, catalyst, method of preparing novel compound or salt thereof and method of preparing mannich product8 Oct 2026US 2026/0308178 A1Okinawa Institute of Science and Technology School Corporation
- Amino acid backbone ionizable lipid, preparation method thereof and application method therefor1 Oct 2026US 2026/0294811 A1South China University of Technology
- Usp30 inhibitors and uses thereof1 Oct 2026US 2026/0297026 A1Vincere Biosciences, Inc.
Most cited
By later US patents
- Delivery of multiple doses of medications377US 5,837,284 A1998
- Antidiabetic 3,4,5-trihydroxypiperidines252US 4,639,436 ABayer Aktiengesellschaft · 1987
- Proline derivatives and related compounds230US 4,105,776 AE. R. Squibb & Sons, Inc. · 1978
- Azetidine-2-carboxylic acid derivatives180US 4,046,889 AE. R. Squibb & Sons, Inc. · 1977
- Cyclic amine compounds with activity against acetylcholinesterase174US 4,895,841 AEisai Co., Ltd. · 1990